These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8335522)

  • 21. Comparison of bactericidal activity of selected beta-lactam antimicrobials against Pseudomonas aeruginosa.
    Smith JA; Henry DA
    J Antimicrob Chemother; 1988 Dec; 22(6):849-55. PubMed ID: 3149632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro.
    Barclay ML; Begg EJ; Chambers ST; Boswell DR
    Antimicrob Agents Chemother; 1995 Jan; 39(1):132-6. PubMed ID: 7695294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation on optimal regimen of ceftazidime against infection caused by Pseudomonas aeruginosa using Monte Carlo simulation].
    Mikamo H
    Jpn J Antibiot; 2007 Dec; 60(6):387-93. PubMed ID: 18447208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis.
    Bensman TJ; Wang J; Jayne J; Fukushima L; Rao AP; D'Argenio DZ; Beringer PM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo impact of the MexAB-OprM efflux system on beta-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection.
    Boutoille D; Jacqueline C; Le Mabecque V; Potel G; Caillon J
    Int J Antimicrob Agents; 2009 May; 33(5):417-20. PubMed ID: 19157801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.
    Gerber AU; Feller C; Brugger HP
    Eur J Clin Microbiol; 1984 Dec; 3(6):592-7. PubMed ID: 6098475
    [No Abstract]   [Full Text] [Related]  

  • 27. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents.
    Pitt TL; Sparrow M; Warner M; Stefanidou M
    Thorax; 2003 Sep; 58(9):794-6. PubMed ID: 12947141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan.
    Horikoshi Y; Higuchi H; Suwa J; Isogai M; Shoji T; Ito K
    J Infect Chemother; 2016 Aug; 22(8):532-5. PubMed ID: 27263807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.
    Ullmann U
    Chemotherapy; 1977; 23(5):314-23. PubMed ID: 409590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model.
    Ghazi IM; Monogue ML; Tsuji M; Nicolau DP
    Int J Antimicrob Agents; 2018 Feb; 51(2):206-212. PubMed ID: 29111435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.
    Gerber AU; Craig WA
    J Lab Clin Med; 1982 Nov; 100(5):671-81. PubMed ID: 6813409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy of neutropenic rats infected with Pseudomonas aeruginosa.
    Lumish RM; Norden CW
    J Infect Dis; 1976 May; 133(5):538-47. PubMed ID: 816976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
    Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H
    Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vivo assessment of in-vitro killing patterns of Pseudomonas aeruginosa.
    Gerber AU; Feller-Segessenmann C
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():201-6. PubMed ID: 3920180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection.
    Hill L; Veli N; Coote PJ
    Int J Antimicrob Agents; 2014 Mar; 43(3):254-61. PubMed ID: 24361354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of dosage regimens on the efficacy of piperacillin against Pseudomonas aeruginosa in neutropenic mice.
    Zhi JG; Nightingale CH; Quintiliani R
    J Pharm Sci; 1988 Nov; 77(11):991-2. PubMed ID: 3225762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.